Skip to main content
Rosalind Franklin University of Medicine and Science

Rosalind Franklin University of Medicine and Science

Rosalind Franklin University is a graduate-level institution with 2,000 students dedicated to health sciences and located in North Chicago, Illinois, approximately 35 miles north of downtown Chicago. Its beautiful 97-acre campus is home to the Basic Science Building, the Health Science Building, the Morningstar Interprofessional Education Center, Multi-media Dr. John J. Sheinin Gross Anatomy Lab, Education and Evaluation Center, three student residence halls and the Rosalind Franklin University Health System. RFU is a national leader in interprofessional medical and healthcare education, offering a doctor of medicine program through the Chicago Medical School, doctor of podiatric medicine program through the Dr. William M. Scholl College of Podiatric Medicine, a doctor of pharmacy through the College of Pharmacy, and a range of degrees through its College of Health Professions, including nurse anesthesia, nutrition, physical therapy, pathologists’ assistant and physician assistant. The University also offers advanced biomedical degrees through the School of Graduate and Postdoctoral Studies. In 2018, the university broke ground on the Innovation and Research Park, which will add nearly 100,000 square feet of space to campus. The park continues our heritage of research that impacts the world.www.rosalindfranklin.edu

Search complete. 2 mentions across 2 episodes found for "Rosalind Franklin University of Medicine and Science".

Sep 18, 2026

speaker_1NARRATOR
33:39
Thank you for listening to this episode of Helix Talk.
speaker_1NARRATOR
33:42
This is an educational production, copyright Rosalind Franklin University of Medicine and Science.
Raj ChovatiyaHOST
0:10
My name is Raj Chobatia.
Raj ChovatiyaHOST
0:11
I'm an associate professor at the Rosalind Franklin University of Medicine and Science, Chicago Medical School, and founder and director of the Center for Medical Dermatology and Immunology Research in Chicago, Illinois.
Raj ChovatiyaHOST
0:22
So today we're going to chat a little bit about GPP, or generalized pustular psoriasis, and in particular, a little bit about our first and only approved targeted treatment option, spizolumab.
Raj ChovatiyaHOST
0:33
But before I jump into little bit about the how and when and why to use spizolumab, it makes a lot more sense to really think about the why behind GPP as a disease with high burden and high need.

We value your privacy

We use cookies to understand how you use our platform and to improve your experience. Click “Accept All” to consent, or “Decline non-essential” to opt out of non-essential cookies. Read our Privacy Policy.